News in brief

Catalent aims to boost drug delivery through industry-academia partnership

Boosting communication between industry and academia is the way to advance drug delivery, says Catalent

Catalent has established a new institute in a bid to advance drug delivery by creating links between industry and academia.

The association – named the Applied Drug Delivery Institute – will provide training programmes, help establish partnerships between universities and business, and will work with regulatory bodies in an effort to solve industry-wide issues.

In a statement, senior VP of research and development (R&D) Kurt Nielsen said: “The mission of the Catalent Applied Drug Delivery Institute is to bring better treatments to market by advancing the development and adoption of applied drug delivery technologies.

Rao Tatapudy, VP of scientific affairs added: “We look forward to a continuous series of successful collaborations as the institute’s activities unfold.”

The firm launched the new organisation during a press conference at AAPS, where we spoke to the programme leaders about the reasons behind the move, the current happenings and what’s to come.

Read the article on next week’s

Related News

Large CROs often prioritise Big Pharma over small to medium firms, according to a PCT panel

SMEs are second best in partnerships with big CROs, says PCT panel

Catalent to supply Akita-based Unigen with cell lines

Catalent signs cell line deal with Japanese CMO

Professor Langer awarded the National Medal of Technology and Innovation

Always Money for Good Ideas says Drug Delivery Pioneer

Open source developers could swipe biz from CROs

Open source paradigm could swipe biz from CROs: Beroe

Catalent completes Aptuit deal

Catalent completes Aptuit deal

Strategic deals drive Catalent’s $410m move for Aptuit assets